Global Biotechnology Market Expected to Reach USD 1,315.9 Billion by 2033 - IMARC Group

Global Biotechnology Market Statistics, Outlook and Regional Analysis 2025-2033

The global biotechnology market size was valued at USD 761.5 Billion in 2024, and it is expected to reach USD 1,315.9 Billion by 2033, exhibiting a growth rate (CAGR) of 6.27% from 2025 to 2033.

The biotechnology market is experiencing rapid growth fueled by advancements in cutting-edge technologies such as CRISPR-Cas9, next-generation sequencing (NGS), and synthetic biology. On 17^th October 2024, Illumina, a global company in DNA sequencing and array-based technologies, released its MiSeq i100 Series of sequencing systems. These new systems will advance the next-generation sequencing capabilities of any laboratory, offering rapid turnaround and ease of use. The MiSeq i100 and MiSeq i100 Plus systems give labs on-site sequencing tools, priced to be affordable and simple to use-even for those without NGS background. Both systems provide room-temperature storage and shipping, so labs can start sequencing immediately without the need to thaw reagents. The rising adoption of these innovations enables precise genetic modifications, making it feasible to address genetic disorders, enhance agricultural productivity, and design microorganisms for industrial use, further driving the market. CRISPR-Cas9 is facilitating gene editing with unmatched precision, driving breakthroughs in gene therapy and personalized medicine. Additionally, progress in genomic research is significantly reducing DNA sequencing costs, promoting its integration into drug development, disease diagnostics, and forensic science which is also supporting the market. Besides this, several companies and research institutions are increasingly harnessing these tools to tackle pressing global challenges, including cancer, rare genetic diseases, and climate change. Moreover, growing investments from governments and private organizations are intensifying competition and collaboration across the sector, propelling the market growth. As genomic technologies continue to advance, their transformative applications in healthcare, agriculture, and environmental solutions are positively influencing the market forward.

Furthermore, biotechnology companies are employing sophisticated diagnostic tools to identify biomarkers, enabling the creation of precision treatments. Notably, CAR-T cell therapies are achieving significant success in treating specific cancer types. Governments and healthcare systems are prioritizing biopharmaceutical innovation to meet unmet medical needs, with regulatory agencies expediting approvals for advanced therapies. On 18^th September 2024, India's government sanctioned the Bio-RIDE scheme with a ₹9,197 crore investment to improve biotechnology research, innovation, and entrepreneurship. The focus will be on biomanufacturing, bio-entrepreneurship and engagement of academia and industry in the advancement of India's bioeconomy. This ongoing rise in biopharmaceutical research and personalized medicine is addressing critical healthcare challenges while supporting biotechnology’s central role in driving the global healthcare market.

Global Biotechnology Market Statistics, By Region

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share on account of robust investments in research and development, advanced healthcare infrastructure, strong government support, and the significant adoption of cutting-edge technologies, such as CRISPR and biopharmaceuticals.

North America Biotechnology Market Trends:

North America holds the position as the largest regional segment in the global market, fueled by substantial investments in research and development and a well-established healthcare infrastructure. The presence of the world's leading biotechnology firms and academic institutions is driving advancements in genetic engineering, biopharmaceuticals, and personalized medicine across the globe. North America’s early adoption of innovative technologies, such as CRISPR-Cas9 and next-generation sequencing, is strengthening its market leadership. Governments and private organizations in the region actively support the biotechnology sector through favorable policies, funding initiatives, and expedited regulatory pathways for breakthrough therapies.

Along with this, the rising prevalence of chronic diseases such as cancer and diabetes are increasing the demand for biopharmaceuticals, fostering the development of cutting-edge treatments. In 2024, approximately 2,001,140 new cancer cases are likely to occur in the United States and 611,720 persons will die from cancer according to National Cancer Institute, US. The most common cancers, listed in descending order according to estimated new cases in 2024, are breast cancer, prostate cancer, lung and bronchus cancer, colon and rectum cancer, melanoma of the skin, bladder cancer, kidney and renal pelvis cancer, non-Hodgkin lymphoma, endometrial cancer, pancreatic cancer, leukemia, thyroid cancer, and liver cancer. Additionally, the region benefits from a skilled workforce and robust collaboration between academia and industry, positioning North America as a key hub for biotechnological innovation and market growth.

Asia Pacific Biotechnology Market Trends:

The Asia Pacific market is rapidly expanding due to investments in research and development and the expansion of healthcare infrastructure. Countries such as China, India, and Japan are witnessing substantial growth due to the various initiatives from the government to facilitate biotechnology innovations, the increasing demand for personalized medicine and biopharmaceuticals, cost-efficient manufacturing, and a growing skilled workforce. Improvements in agricultural biotechnology, along with a rising focus on regional healthcare challenges, such as infectious diseases, are further strengthening the market. Moreover, emerging trends of applying genomic technologies and outsourcing clinical research support Asia Pacific as a significant biotechnology hub.

Europe Biotechnology Market Trends:

Europe’s biotechnology market is expanding steadily, supported by robust government funding, advanced healthcare systems, and strong regulatory frameworks. The region is a leader in biopharmaceutical research, particularly in monoclonal antibodies, cell and gene therapies, and vaccine development. Countries such as Germany, the United Kingdom, and France are at the forefront of innovation, with a strong focus on addressing rare diseases and advancing precision medicine. Europe’s commitment to sustainability is also driving developments in agricultural and environmental biotechnology. Moreover, collaborative efforts between academia and industry, along with a well-established clinical trial ecosystem, position Europe as a key contributor to global biotechnology advancements.

Latin America Biotechnology Market Trends:

The biotechnology market in Latin America is growing, driven by increasing investments in healthcare and the rising need for innovative solutions to combat regional health issues such as infectious diseases and chronic conditions. Countries such as Brazil, Mexico, and Argentina are emerging as biotechnology hubs, supported by favorable government policies and a focus on research collaborations. The agricultural sector is also a significant contributor, with advancements in genetically modified crops aimed at improving food security. While infrastructure and regulatory challenges remain, the region’s expanding workforce and the increasing adoption of biotechnology applications in healthcare and agriculture are positioning Latin America as a market with strong growth potential.

Middle East and Africa Biotechnology Market Trends:

The Middle East and Africa market is gaining traction due to increasing governmental activities and investments to improve healthcare innovation and biotechnology research. Moreover, the increasing focus on countries, including South Africa, Saudi Arabia, and the UAE-the countries that aim to develop biopharmaceuticals vaccines and diagnostic tools to combat the region's specific healthcare issues is also driving the market growth. It is also developing biotechnology to bring agricultural productivity and food security demanded by the masses. Moreover, international cooperation and research hubs in biotechnology are presenting this region with opportunities for market growth.

Top Companies Leading in the Biotechnology Industry

Some of the leading biotechnology market companies include Amgen Inc., Biocon Limited, Biogen Inc., F. Hoffmann-La Roche AG, Genmab A/S, Lonza Group AG, Novartis AG, Novo Nordisk A/S, Pfizer Inc., Regeneron Pharmaceuticals Inc., Seagen Inc., Syngenta AG, and Vertex Pharmaceuticals Incorporated, among many others. On 10^th January 2024, US-based technology company NVIDIA announced a collaboration with Amgen to construct artificial intelligence (AI) models for drug discovery. Amgen will use the AI model-building platform, known as Freyja, at deCODE genetics headquarters in Reykjavik, Iceland. The system is intended to help analyze vast amounts of human datasets for drug targets and discover biomarkers related to diseases, which may help doctors diagnose disease progression and regression. The integration of NVIDIA's DGX SuperPOD data platform with 31 DGX X100 nodes and 248 H100 Tensor Core GPUs will speed up the training of advanced AI models.

Global Biotechnology Market Segmentation Coverage

• On the basis of the product type, the market has been categorized into instruments, reagents, and software and services. Instruments, including advanced tools for genetic engineering and sequencing, form a crucial segment, driving innovation and research applications. Reagents, essential for conducting experiments and assays, represent a significant share due to their widespread use in diagnostics and drug development. Concurrently, the software and services segment is rapidly growing, fueled by the increasing adoption of bioinformatics tools and data analytics to enhance research efficiency and precision. Together, these segments play vital roles in advancing biotechnology applications globally.
• Based on the technology, the market has been categorized into nanobiotechnology, tissue engineering and regeneration, DNA sequencing, cell-based assays, fermentation, PCR technology, chromatography, and others. Nanobiotechnology is revolutionizing the way drugs are delivered and diagnosed. Tissue engineering and regeneration are advancing regenerative medicine. DNA sequencing is driving genomic research and personalized medicine, whereas cell-based assays are allowing for drug discovery and toxicity testing in culture systems. Fermentation plays a cardinal role in producing biopharmaceuticals, PCR technology stands crucial for analyzing genetics, and chromatography ensures a high degree of accuracy in separation techniques.
• On the basis of the application, the market has been divided into healthcare, food and agriculture, natural resources and environment, industrial processing, bioinformatics, and others. Among these, healthcare accounts for the majority of the market share as the demand for biopharmaceuticals and advanced diagnostic tools is increasing at a rapid rate along with personalized medicines. Biotechnological advances are revolutionizing the treatment of diseases, as novel therapies such as monoclonal antibodies, gene editing, and cell-based therapies reach into the complex conditions of cancer, diabetes, and many other rare genetic diseases. The segment also is fueled by the growing prevalence of chronic diseases and the rising adoption of genomic and proteomic research.

Browse IMARC Related Reports on Biotechnology Market:

• Japan Biotechnology Market Report
   
• Vietnam Biotechnology Market Report
   
• South East Asia Biotechnology Market Report
   
• United States Biotechnology Market Report
   
• Saudi Arabia Biotechnology Market Report